urothelial cancer

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Urothelial Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Gemcitabine)

Recruiting
  • Urothelial Cancer
  • Nivolumab
  • +4 more
  • Birmingham, Alabama
  • +196 more
Jan 17, 2023

Carcinoma, Transitional Cell, Urinary Bladder Tumors, Urologic Tumors Trial in Worldwide (enfortumab vedotin (EV),

Active, not recruiting
  • Carcinoma, Transitional Cell
  • +6 more
  • enfortumab vedotin (EV)
  • +4 more
  • Anchorage, Alaska
  • +105 more
Dec 19, 2022

Urothelial Cancer Trial in Worldwide (Erdafitinib, Vinflunine, Docetaxel)

Recruiting
  • Urothelial Cancer
  • Anchorage, Alaska
  • +414 more
Jul 14, 2022

Urothelial Cancer Trial in Worldwide (TKI258)

Completed
  • Urothelial Cancer
  • La Jolla, California
  • +25 more
Dec 11, 2020

Neoadjuvant Cisplatin-based Chemotherapy in Urothelial Cancer

Completed
  • Urothelial Cancer
    • Chicago, Illinois
      University of Chicago
    May 1, 2018

    Urothelial Cancer Trial in United States (Gemcitabine, Cisplatin, Sunitinib)

    Completed
    • Urothelial Cancer
    • Gemcitabine, Cisplatin, Sunitinib
    • Tucson, Arizona
    • +47 more
    Sep 15, 2016